Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 5.08 M10.78 M — Research & development —— — Operating income -3.27 M968 K — Non-Operating Income, Total 76.18 M8.99 M — Interest expense, net of interest capitalized —— — Non-Operating Income, excl. Interest Expenses 76.18 M8.99 M — Unusual income/expense —— — Pretax income 70.42 M4.08 M — Equity in earnings —24 K — Taxes 3 0007 000 — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations 69.43 M4.09 M — Discontinued operations 495 K965 K — Net income 69.93 M5.05 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 69.74 M5.05 M — Basic earnings per share (Basic EPS) 15.05-0.65 — Diluted earnings per share (Diluted EPS) 15.05-0.65 — Average basic shares outstanding 4.64 M7.74 M — Diluted shares outstanding 4.64 M7.74 M — EBITDA -2.88 M2.69 M — EBIT -3.27 M968 K — Cost of revenue 6.36 M12.12 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) 394 K1.72 M —